Georgina V Long Selected Research

Georgina V Long Research Topics

Disease

375	Melanoma (Melanoma, Malignant) 06/2024 - 04/2011
146	Neoplasms (Cancer) 04/2024 - 03/2012
74	Neoplasm Metastasis (Metastasis) 05/2024 - 12/2012
29	Brain Neoplasms (Brain Tumor) 01/2024 - 03/2012
25	Disease Progression 11/2023 - 11/2012
11	Fever (Fevers) 01/2021 - 11/2012
6	Colitis 01/2024 - 01/2019
6	Lymphatic Metastasis 01/2022 - 01/2019
6	Autoimmune Diseases (Autoimmune Disease) 11/2021 - 02/2016
5	Uveal melanoma 12/2023 - 01/2020
5	Inflammation (Inflammations) 01/2023 - 01/2017
5	Body Weight (Weight, Body) 10/2019 - 01/2015
5	Squamous Cell Carcinoma (Epidermoid Carcinoma) 05/2015 - 04/2014
4	Pneumonia (Pneumonitis) 01/2022 - 01/2017
4	Fatigue 01/2019 - 01/2015
3	Skin Neoplasms (Skin Cancer) 02/2024 - 04/2014
3	Pain (Aches) 02/2024 - 05/2015
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2024 - 01/2021
3	Hypophysitis 01/2023 - 08/2014
3	Encephalitis (Encephalitis, Rasmussen) 12/2022 - 01/2019
3	Glioma (Gliomas) 12/2022 - 01/2020
3	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2019
3	Neutropenia 01/2021 - 11/2012
3	Nevus (Nevi) 01/2019 - 07/2012
2	Sarcoma (Soft Tissue Sarcoma) 06/2024 - 10/2014
2	Squamous Cell Carcinoma of Head and Neck 10/2023 - 01/2019
2	Overweight 01/2023 - 01/2018
2	Hypertension (High Blood Pressure) 11/2022 - 01/2017
2	Exanthema (Rash) 11/2022 - 01/2019
2	Thyrotoxicosis 01/2022 - 01/2021
2	COVID-19 01/2022 - 01/2021
2	Lung Neoplasms (Lung Cancer) 01/2022 - 01/2022
2	Hypothyroidism 01/2022 - 01/2021

Drug/Important Bio-Agent (IBA)

82	Immune Checkpoint InhibitorsIBA 04/2024 - 02/2015
63	dabrafenibIBA 05/2024 - 01/2012
61	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 03/2024 - 11/2012
59	pembrolizumabIBA 03/2024 - 06/2015
57	IpilimumabIBA 01/2024 - 01/2013
56	NivolumabIBA 02/2024 - 01/2015
53	trametinibIBA 05/2024 - 11/2012
40	Biomarkers (Surrogate Marker)IBA 12/2023 - 05/2012
20	VemurafenibIBA 01/2018 - 03/2012
19	Proteins (Proteins, Gene)FDA Link 01/2024 - 01/2012
19	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 01/2013
16	AntibodiesIBA 01/2024 - 09/2013
14	LigandsIBA 01/2023 - 07/2015
13	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 06/2024 - 03/2016
12	B7-H1 AntigenIBA 01/2023 - 03/2014
10	SteroidsIBA 05/2024 - 10/2014
10	RNA (Ribonucleic Acid)IBA 04/2024 - 01/2020
9	Circulating Tumor DNAIBA 01/2022 - 12/2015
9	Dacarbazine (DIC)FDA LinkGeneric 11/2020 - 01/2012
9	Phosphotransferases (Kinase)IBA 01/2020 - 12/2014
8	Formaldehyde (Formol)FDA Link 01/2023 - 01/2013
8	Mitogen-Activated Protein KinasesIBA 10/2022 - 01/2012
7	relatlimabIBA 10/2023 - 01/2022
7	ParaffinIBA 01/2023 - 01/2013
7	CytokinesIBA 01/2023 - 03/2014
6	Programmed Cell Death 1 ReceptorIBA 09/2023 - 11/2018
6	AntigensIBA 01/2023 - 11/2020
5	Monoclonal AntibodiesIBA 01/2022 - 01/2017
5	CateninsIBA 12/2017 - 01/2014
5	Proto-Oncogene Proteins B-rafIBA 09/2015 - 09/2013
4	spartalizumabIBA 01/2023 - 10/2020
4	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2022 - 10/2014
4	Cell-Free Nucleic AcidsIBA 11/2020 - 09/2013
3	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 02/2024 - 10/2014
3	Messenger RNA (mRNA)IBA 01/2024 - 01/2018
3	bempegaldesleukinIBA 10/2023 - 10/2020
3	atezolizumabIBA 01/2023 - 01/2018
3	ChemokinesIBA 01/2023 - 03/2014
3	Interleukin-6 (Interleukin 6)IBA 01/2022 - 01/2019
3	MART-1 AntigenIBA 12/2021 - 09/2013
3	GlucocorticoidsIBA 11/2021 - 11/2020
3	CTLA-4 AntigenIBA 10/2020 - 03/2014
3	EnzymesIBA 01/2019 - 01/2017
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2017 - 03/2014
2	Interferon-gamma (Interferon, gamma)IBA 04/2024 - 12/2023
2	Acetaminophen (Paracetamol)FDA LinkGeneric 02/2024 - 10/2014
2	binimetinibIBA 01/2024 - 01/2017
2	Bispecific AntibodiesIBA 12/2023 - 10/2022
2	Metformin (Glucophage)FDA LinkGeneric 01/2023 - 01/2020
2	cobimetinibIBA 01/2023 - 01/2018
2	talimogene laherparepvecIBA 01/2023 - 09/2017
2	Differentiation AntigensIBA 01/2023 - 12/2020
2	Immunoglobulin G (IgG)IBA 01/2023 - 01/2021
2	Leucine (L-Leucine)FDA Link 12/2022 - 11/2022
2	Dihydrotachysterol (AT 10)IBA 11/2022 - 01/2021
2	Lipase (Acid Lipase)FDA Link 11/2022 - 11/2012
2	cyclopropapyrroloindoleIBA 10/2022 - 01/2022
2	Interleukin-2 (IL2)IBA 01/2022 - 06/2014

Therapy/Procedure

220	Therapeutics 06/2024 - 04/2011
106	Immunotherapy 04/2024 - 09/2012
19	Drug Therapy (Chemotherapy) 08/2023 - 01/2012
12	Radiotherapy 10/2023 - 01/2013
11	Neoadjuvant Therapy 05/2024 - 01/2019
10	Lymph Node Excision (Lymph Node Dissection) 05/2024 - 01/2019
5	Aftercare (After-Treatment) 01/2023 - 03/2012
3	Retreatment 01/2023 - 01/2018
2	Salvage Therapy 11/2023 - 01/2023